The trouble is unless we get agreements/collaberation with other pharma to take our products forward then we will need lots of funding surely. Hemo is not going to be able to get its products to market unless it sells them. 12 million would not cover the developement to phase 3. I don't think we will go bust but may end up in other \pharmas hands at a fraction of the price.
JHFH thats a bit unfair to Tuan. Remember you said that Mint would never convert at this level and bring the price down. Not trying to be argumentative. None of us really know enough to give anyone insight on these boards!
The trouble is people are to scared to put in more fearing further dilution. We need solid news on what the money is being spent on with firm timelines and outcomes. An alternative finance plan altough I would think that is doubtful and new interest and volume.
I feel we are cuurently being valued at our cash value not taking into count our potential products so I suppose as more shares are issued the price will fall to reflect the 12,000,000 to the shares in circulation. If Hemo repay Mint with the costs incurred I wonder if we could be valued at even less unless more financing is available. I don't see how we can move forward at the moment while these doubts persist.
But thats not how some described Mint at the time. It was said they were a leading visionary who wanted to help support and bring our buisness forward. They would never convert at such low levels. I am stuck in here with a loss as I didn't follow my gut instinct about Mint and financing that I should have learned from companies like UKOG. Thats my fault. I just don't want others to risk averaging down until we are sure there is a way forward although it is not my place to say what anyone does with there investments.
JHFH Surely there will be a huge cost to Hemo from cancelling the finance deal with Mint. What it would cost to pay back the loan would leave us nothing to show for this whole episode other than dilution of share holder value and no capital going forward. We are surely stuck with this sorry affair now and can only hope on some better detail on how the 12 million or what is left will be spent. Please anyone correct me if I am wrong as I would love to be!
Nothing has really changed other than our product doesn't make much difference to people who are not that poorly. The same could be said of Paracetamol if you got a minor temperature you don't really notice the benefit but if you are 39degrees plus you do. At least as I am sure people have said the results shows your target patient. We have drugs for all sorts of conditions that are not in the home but emergency setting so we will just fall into that catagory I am sure. Thats not to say now it has been shown to be able to be administered safely in the comunity that trratment couldn't be started in hospital or by a health care professional and continued in the home setting thus freeing up Hospital places and reducing further transmission risks. The Hospitals have got big catch ups to make on many other medical and surgical problems now Covid is more controlled.
Maybe Mint were as caught out by the Eli result as we all were. They will make money no matter what but its going to be more difficult for them to offload at these very low levels without owning to higher percentage in the company. I expect for them a vaster trading range would be more beneficial!
Well it seems to have settled here for the time being. With the additional shares around about how much we have in cash. Not valuing our potential products. I expect until any market confidence(I know that has been seriously knocked) our cash value will be where we gage our share price.